Hi @Davisite
Saw your RR on the other thread and nicely written. Have to admit, the mining focus hides your underlying profession but good to see as there's not enough professional level analysis on HC - especially for bios. Keen to see more, time permitting.
Slim pickings on the ASX in my view but have found (regarding specs) a nice RR strategy is to buy well out from key trials and let market expectation/positioning do the work for you. Sell before. Can't remember missing too many that have gone on with it and managed not to give profits back. One way to skin the cat.
fwiw, I rate OPT, 1AD and PTX as speculative opportunities for next year (none currently held) and I hold EX1 as a speculative punt.
Plenty of others names that will prove to be good traders, like the crazy bio run we saw a month or so ago. VSTT isn't my thing and I'm guessing you're looking more at investment grade companies?
Cheers.
- Forums
- Commodities
- Biotech Analysts $4M pa
Biotech Analysts $4M pa, page-3
-
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
UNT
UNITH LTD
Idan Schmorak, CEO
Idan Schmorak
CEO
Previous Video
Next Video
SPONSORED BY The Market Online